Spectrum Pharmaceuticals, Inc. - Common Stock (NQ:SPPI)

SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI

June 30, 2023

From Kahn Swick & Foti, LLC

With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors.

Are (More) Big Gains Ahead for This Small Cap Biotech Stock?

June 28, 2023

Via MarketBeat

Topics Initial Public Offering

Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

May 17, 2023

Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:ENZC) 300% Run: RMED, SPPI, HALB, VXRT

May 12, 2023

Via AB Newswire

Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

May 09, 2023

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR)

May 01, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

April 25, 2023

From Kahn Swick & Foti, LLC

SPPI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Spectrum Pharmaceuticals, Inc. Is Fair to Shareholders

April 25, 2023

From Brodsky & Smith LLC

Via GlobeNewswire

April 25, 2023

From Halper Sadeh LLC

NASDAQ:SPPI Long Term Shareholder Alert: Investigation over Possible Wrongdoing at Spectrum Pharmaceuticals, Inc. ↗

March 23, 2023

San Diego, CA -- (SBWIRE) -- 03/23/2023 -- Certain directors of Spectrum Pharmaceuticals, Inc. are under investigation over potential breaches of fiduciary duties.

Via SBWire

Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update

March 22, 2023

Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update

March 17, 2023

Spectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services

February 08, 2023

Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate

February 03, 2023

From Bronstein, Gewirtz & Grossman, LLC

DEADLINE TODAY: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

February 03, 2023

From The Schall Law Firm

SPPI FINAL DEADLINE TOMORROW: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 3 Deadline in Securities Class Action - SPPI

February 02, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm

Topics Lawsuit

February 02, 2023

From The Schall Law Firm

Spectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results

January 31, 2023

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Notice: Deadline in Lawsuit on February 6, 2023 ↗

January 30, 2023

San Diego, CA -- (SBWIRE) -- 01/30/2023 -- The Shareholders Foundation announced a deadline is coming up on February 6, 2023 in the lawsuit filed for certain investors of Spectrum Pharmaceuticals, Inc....

Via SBWire

SPPI IMPORTANT DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

January 28, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Topics Lawsuit

Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff

January 26, 2023

From Spectrum Pharmaceuticals

ROSEN, A LONGSTANDING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

January 24, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

Topics Lawsuit

January 22, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, A RESPECTED AND LEADING FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

Topics Lawsuit

January 16, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

Topics Lawsuit

January 13, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NASDAQ:SPPI Investor Alert: Lawsuit Alleges Misleading Statements by Spectrum Pharmaceuticals, Inc. ↗

Topics Lawsuit

January 11, 2023

San Diego, CA -- (SBWIRE) -- 01/11/2023 -- An investor, who purchased NASDAQ:SPPI shares, filed a lawsuit against Spectrum Pharmaceuticals, Inc. over alleged violations of Federal Securities Laws.

Via SBWire

ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action– SPPI

January 10, 2023

From The Rosen Law Firm PA

Via GlobeNewswire

ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI

January 07, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Topics Lawsuit

Spectrum Pharmaceuticals Announces Management Changes

January 04, 2023